The SOLO MicroPump Insulin Delivery System is a patch pump originally made by Medingo and purchased by Roche in 2010. Solo received FDA approval in 2009 and is expected to be available in 2012. The system has 4 parts: a micropump composed of reusable electronics plus an insulin reservoir, a remote, and a cradle.
The Debiotech JewelPump is a disposable patch pump with some similarities to the current Omnipod, as well as other patch pumps on the horizon. Debiotech, a Swiss company, teamed with ST Microelectronics to create this sleek pump system. Like most patch pumps, a separate controller is required to deliver bolus insulin doses. It use a microelectromechanical (MEMS) pumping system, that allows the pump to be kept small and light.
The Cellnovo Diabetes Management System includes an insulin patch pump, continuous activity monitor, and a cellular-enabled wireless touchscreen handset with integrated blood glucose meter. Their semi-patch pump (patch pump with a nearby infusion site) got a lot of attention in 2009 when it was first announced because of its small size and iPhone-like handset. They received CE approval in September of 2011 and expects to receive FDA approval in the US. They filed for 510(k) in November of 2016 and responded to a series of FDA questions in August of 2017. The FDA has requested further information, but approval is anticipated in 2018.
SUNNYVALE, Calif., May 17, 2011 – Asante Solutions, Inc. (Asante), a medical device company focused on diabetes care, announced that the U.S. Food and Drug Administration has granted 510(k) clearance for the company's Pearl Insulin Pump. Last month, the Pearl also received the CE Mark, a European proof of conformity that certifies the product meets EU safety, health and environmental requirements.